Skip to main content
. Author manuscript; available in PMC: 2021 Feb 26.
Published in final edited form as: Anesth Analg. 2019 Jan;128(1):25–32. doi: 10.1213/ANE.0000000000003538

Table 1.

Preoperative Baseline Characteristics

Demographics and Preoperative Characteristics Nonsevere RVF (n = 57) Severe RVF (n = 28) P Value
Age 55 ± 12 56 ± 11 .58
Male sex: N (%) 44 (78.57) 24 (85.71) .22
Body mass index 28.16 ± 6.03 28.08 ± 6.35 .96
Body surface area 1.95 ± 0.23 2.01 ± 0.34 .32
Ischemic CM (versus nonischemic) 19 (33.93) 7 (25.00) .45
Re-do sternotomy 11 (19.64) 4 (14.29) .76
Preoperative mechanical ventilation: N (%) 0 (0) 1 (3.70) .33
LVEF <20%: N (%) 52 (92.86) 27 (96.43) .66
CRF (Cr > 2.3 mg/dL): N (%) 3 (5.00) 2 (8.00) .74
Nonsevere RVF Severe RVF P Value
Laboratory variables
 Creatinine (mg/dL) 1.22 ± 0.52 1.43 ± 0.72 .13
 BUN (mg/dL) 23.57 ± 14.29 33.07 ± 14.89 .01
 AST (IU/L) 28.21 ± 19.83 32.54 ± 14.89 .31
 Total bilirubin (mg/dL) 0.97 ± 0.75 1.43 ± 1.02 .02
Support device variables
 HeartWare device: N (%) 36 (64.29) 18 (64.29) >.99
 HeartMate device: N (%) 20 (35.71) 10 (35.71) >.99
 Bridge to transplant: N (%) 37 (66.07) 20 (71.43) >.99
Scoring variables
 INTERMACS score 2.35 ± 0.85 2.81 ± 0.72 .01
 RVFRS: median (interquartile range) 0 (0, 0) 0 (0, 2.5) .09a

All data are presented as mean ± standard deviation or N (%) except where noted. Comparisons are made with 2-tailed t test and χ2 tests.

Abbreviations: AST, aspartate aminotransferase; BUN, blood urea nitrogen; CM, cardiomyopathy; CRF, chronic renal failure; HbA1c, Hemoglobin A1c; INTERMACS, interagency registry for mechanically assisted circulatory support; LVEF, left ventricular ejection fraction; RVF, right ventricular failure; RVFRS, right ventricular failure risk score.

a

Mann-Whitney U test.